Anovel enoxaparin regimen for ST-elevation myocardial infarctionpatients undergoing primary percutaneous coronary intervention: intravenous but not subcutaneous enoxaparin achieves adequate anti-Xa levels - Welsh, RC; Gordon, P; Westerhout, CM (JAmColl Cardiol, 2006)
(Abstract).